Related Experiment Video

Updated: Sep 20, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K

Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma

Tanja Eisemann1, Robert J Wechsler-Reya1,2

  • 1Tumor Initiation and Maintenance Program, National Cancer Institute-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, USA.

Genes & Development
|June 9, 2022
PubMed

Insights

Medulloblastoma, a pediatric brain tumor, is challenging to treat. Emerging research suggests immunotherapy may be a viable option, offering new hope for patients.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Immunology

Background:

  • Medulloblastoma is a highly aggressive pediatric brain tumor with poor outcomes.
  • Current therapies are insufficient, necessitating novel treatment strategies.
  • Medulloblastoma has been considered resistant to immunotherapy due to its characteristics.

Purpose of the Study:

  • To review current preclinical and clinical evidence regarding medulloblastoma and immunotherapy.
  • To identify mechanisms of immune evasion in medulloblastoma.
  • To highlight potential immunotherapy interventions for medulloblastoma.

Main Methods:

  • Review of recent preclinical studies.
  • Analysis of clinical trial data.
  • Synthesis of research on medulloblastoma immune microenvironment.

Main Results:

  • Medulloblastoma exhibits immune-evasive properties.
  • Emerging evidence challenges the notion of immunotherapy resistance.
  • Specific therapeutic targets and strategies are being identified.

Conclusions:

  • Immunotherapy may offer a promising new avenue for treating medulloblastoma.
  • Further research into immune evasion mechanisms is crucial.
  • Targeted immunotherapies could improve outcomes for pediatric patients.
Keywords:
CAR T cellantigen presentationimmune checkpointimmunotherapymedulloblastomamyeloid celloncolytic viruspediatric brain tumorvaccination

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.0K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
509
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
74.4K